Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease
A clinical trial from Sakarya University is currently recruiting to evaluate muscle strength and muscle mass in patients with Crohn's diseas…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
A recruiting clinical trial is comparing guselkumab to ustekinumab for Crohn's disease with intestinal strictures, sponsored by Zhejiang Uni…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Development of New Diagnostic Tools in Capsule Endoscopy
This clinical trial update reports progress in developing capsule endoscopy-based diagnostic tools for bowel diseases, including Crohn's dis…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Impact of Prebiotics in Ulcerative Colitis [NA]
A UCLA-sponsored clinical trial is investigating the impact of prebiotics in ulcerative colitis, with Crohn's disease also listed; the study…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease
A Cairo University-sponsored clinical trial update on health-related quality of life in inflammatory bowel disease, including ulcerative col…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
Takeda is providing expanded access to vedolizumab for children and teenagers with Crohn's disease or ulcerative colitis in the United State…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
This clinical trial update reports ongoing recruitment for evaluating ustekinumab in patients with symptomatic stricturing Crohn's disease.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Mindfulness-based Stress Reduction Program for IBD [NA]
This clinical trial update describes a mindfulness-based stress reduction program being studied for inflammatory bowel disease, including Cr…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Effect of Statins on Crohn's Disease [EARLY_Phase 1]
A clinical trial is evaluating the effect of statins on Crohn's disease in early-phase research; recruitment is ongoing.
-
FDA approval · 2026-02-25FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ENTYVIO (vedolizumab) submitted by Takeda Pharmaceuticals America, Inc., to support an expanded …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA [NA]
A clinical trial registry entry for a partial enteral nutrition approach aimed at preventing weight loss and sarcopenia in inflammatory bowe…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil
Clinical trial update for adults with inflammatory bowel disease receiving Vedolizumab in a patient support program in Brazil; study status …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease [NA]
This ClinicalTrials.gov entry describes a study evaluating partial enteral nutrition as an adjunct to advanced pharmacological therapy for p…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions
This clinical trial investigates virtual histology of Crohn's disease ex-vivo resected anatomical lesions and is currently not yet recruitin…
-
EMA approval · 2026-02-24EMA Authorised: Fymskina (ustekinumab) — Formycon AG
The EMA authorised Fymskina, an ustekinumab biosimilar from Formycon AG, for Crohn's disease, psoriasis, and psoriatic arthritis.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
An observational study sponsored by AbbVie in Japan enrolling adolescents and adults with moderate to severe Crohn's disease to assess chang…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy [NA]
This clinical trial update describes a remote patient and medication monitoring solution designed to improve adherence and persistence with …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: The Assessment of Infrared Treatment for Crohn's Disease [NA]
A clinical trial is recruiting to assess infrared treatment for Crohn's disease, an inflammatory bowel disease.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease [Phase 2]
The document reports a Phase 2 clinical trial evaluating Zasocitinib (TAK-279) in adults with active Crohn's disease. The study is currently…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Pilot Study of Posaconazole in Crohn's Disease [Phase 4]
A Phase 4 pilot study of posaconazole in Crohn's disease with the CARD9 S12N risk allele was terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
A real-world study evaluating the effectiveness of second-line therapy with upadacitinib and risankizumab in adults with Crohn's disease; th…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease [Phase 1]
Phase 1 study of PALI-2108 in healthy volunteers and patients with ulcerative colitis or fibrostenosing Crohn's disease is active but not re…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease [Phase 2]
This is a Phase 2 clinical trial update for DB-3Q bmMSC-EVs in patients with perianal fistulizing Crohn's disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease [Phase 4]
An ongoing Phase 4 study evaluating dual-targeted therapy with upadacitinib plus ustekinumab versus intensified ustekinumab in Crohn's disea…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Stem Cell Transplantation in Crohn's Disease [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 stem cell transplantation study for Crohn's disease that is currently recruiting.